Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report

Qiu-Yu Li1, Zhuo-Yu An2, Chao Li3

  • 1Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.

Insights

Pregnant women with chronic active hepatitis B face risks when infected with COVID-19. This case report details successful treatment using liver support, antivirals, and dexamethasone for a critically ill patient.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Maternal-Fetal Medicine

Background:

  • Pregnancy increases susceptibility to severe outcomes from infections like COVID-19.
  • Chronic active hepatitis B (CAH-B) is a significant underlying condition that can complicate viral infections during gestation.

Observation:

  • A 31-year-old pregnant woman at 29 weeks gestation, with a history of chronic hepatitis B virus infection, presented with acute exacerbation of CAH-B after discontinuing antiviral therapy.
  • She concurrently tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19.

Findings:

  • The patient received a combination of liver-protective agents, antiviral medications, and low-dose dexamethasone therapy.
  • This multimodal treatment approach led to the successful management of her critical condition.

Implications:

  • This case highlights the complex interplay between COVID-19 and chronic active hepatitis B in pregnancy.
  • It demonstrates the potential efficacy of a targeted therapeutic strategy in managing critically ill pregnant patients with co-infections.
  • Further research into managing co-infected pregnant populations is warranted.